Dose-Finding Study Of CP-675,206 And SU011248 In Patients With Metastatic Renal Cell Carcinoma

Clinical trial NCT00372853 · COMPLETED

Trial details

NCT number: NCT00372853
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Renal Cell

Start date: 2006-11-01
Primary completion: 2010-05-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.